Anthelios Ultra-Light Invisible Fluid Tinted SPF 50+
Exceptionally high protection tinted facial sunscreen in an ultra-lightweight formula for normal to combination skin.
SPECIFICALLY FORMULATED FOR
This sunscreen is specifically formulated for the face and is suitable for normal to combination skin that is prone to sensitivity, sun-intolerance or prickly-heat. This easy-to-apply, ultra light fluid is non-greasy with a lightly-tinted finish for a unified look. It ensures a very high, broad, and photostable UVA/UVB protection with an optimal SPF of 50+. It also helps protect against the effects of infrared. Water resistant.
- A lightweight fluid sunscreen for normal to combination skin
- Exceptionally high broad, photostable UVA/UVB/Infrared protection
- Lightly tinted non-greasy and invisible formula
Exceptionally high, broad photostable UVA/UVB and Infrared protection. Optimal SPF 50+ protection reinforced against UVA rays (stricter than the European recommendation) thanks to patented filtering system Mexoplex® combined with La Roche-Posay Thermal Spring Water.
Anthelios efficacy has been demonstrated via clinical studies carried out in-vivo on subjects suffering from sun intolerances, particularly those caused by UVA rays. Anthelios products all have a high PPD (Persistent Pigment Darkening) factor, offering one of the best protections against UVA offered by any brand in the world. The efficacy has been proven by a file of 16 clinical studies carried out by world-renowned expert dermatologists. The brand was also the first laboratory to use Mexoryl XL and Mexoryl SX and the first to use photostable UVA filters in its sun protection.
9/10 of dermatologists would recommend Anthelios*
MINIMALIST HYPO-ALLERGENIC FORMULA
The minimalist formula contains the best of our creations – designed for sensitive skin and all of its needs. Tested and re-tested for its efficacy and mildness on sensitive skin. It is also hypoallergenic.
This is a cosmetic product. For medical conditions seek advice from your GP
*Survey conducted on 249 dermatologists who chose to attend a La Roche-Posay sponsored symposium in the UK, July 2016